UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations

Journal of rheumatology. Supplement, 2014-05, Vol.91, p.41-46

2014

Volltextzugriff (PDF)

Obesity and inflammation--targets for OA therapy

Current drug targets, 2010-05, Vol.11 (5), p.586-598

2010

Volltextzugriff (PDF)

Renal complications and scleroderma renal crisis

Rheumatology (Oxford, England), 2009-06, Vol.48 (suppl-3), p.iii32-iii35

2009

Volltextzugriff (PDF)

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

Clinical rheumatology, 2018-02, Vol.37 (2), p.315-321

2018

Volltextzugriff (PDF)

FRI0145 A bayesian network meta-analysis on efficacy of biologics and small molecules in early rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.616

2018

Volltextzugriff (PDF)

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

Journal of antimicrobial chemotherapy, 2019-11, Vol.74 (11), p.3295-3304

2019

Volltextzugriff (PDF)

POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.582-582

2021

Volltextzugriff (PDF)

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

Infection, 2024-06, Vol.52 (3), p.737-765

2024

Volltextzugriff (PDF)

FRI0075 Risk of hepatitis b infection reactivation in rheumatic diseases patients treated with anti-cd20 therapy

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.583

2018

Volltextzugriff (PDF)

Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study

Scandinavian journal of rheumatology, 2018-07, Vol.47 (4), p.311-318

2018

Volltextzugriff (PDF)

THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.296

2018

Volltextzugriff (PDF)

AB0709 Switching from originator infliximab to biosimilar infliximab: efficacy and safety in a cohort of patients with established behÇet’s disease

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1494

2018

Volltextzugriff (PDF)

The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases

International Journal of Immunopathology and Pharmacology, 2014-01, Vol.27 (1_suppl), p.1-10

2014

Volltextzugriff (PDF)

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

Journal of antimicrobial chemotherapy, 2018-12, Vol.73 (12), p.3460-3470

2018

Volltextzugriff (PDF)

Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA

Scandinavian journal of rheumatology, 2015-05, Vol.44 (3), p.192-199

2015

Volltextzugriff (PDF)

Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies

Scandinavian journal of rheumatology, 2015-05, Vol.44 (3), p.224-228

2015

Volltextzugriff (PDF)

THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.303

2018

Volltextzugriff (PDF)

OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.115

2018

Volltextzugriff (PDF)

Adalimumab in the Treatment of Immune-Mediated Diseases

International Journal of Immunopathology and Pharmacology, 2014-01, Vol.27 (1_suppl), p.33-48

2014

Volltextzugriff (PDF)

SAT0265 Secondary Sjogren's Syndrome in Patients with Spondyloarthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.754-755

2015

Volltextzugriff (PDF)

Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)

Reumatismo, 2016-12, Vol.68 (3), p.126-136

2016

Volltextzugriff (PDF)

Bosentan fosters microvascular de-remodelling in systemic sclerosis

Clinical rheumatology, 2012-12, Vol.31 (12), p.1723-1725

2012

Volltextzugriff (PDF)

Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

Reumatismo, 2011-09, Vol.57 (4s), p.22-29

Lapadula, G.

2011

Volltextzugriff (PDF)

AB0770 Rheuma-card: involvement of the patient through a secure systems access into the treat to target strategy in rheumatology

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A1025-A1025

2013

Volltextzugriff (PDF)

Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension

Annals of the rheumatic diseases, 2008-08, Vol.67 (8), p.1121-1126

2008

Volltextzugriff (PDF)

1 – 25 von 393

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(367)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations

Obesity and inflammation--targets for OA therapy

Renal complications and scleroderma renal crisis

Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA

FRI0145 A bayesian network meta-analysis on efficacy of biologics and small molecules in early rheumatoid arthritis

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

POS0675 THE COMPARATIVE 3-YEAR RETENTION RATE OF TARGETED-SYNTHETIC AND BIOLOGIC DRUGS FOR RHEUMATOID ARTHRITIS: REAL-LIFE DATA FROM THE ITALIAN GISEA REGISTRY

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

FRI0075 Risk of hepatitis b infection reactivation in rheumatic diseases patients treated with anti-cd20 therapy

Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study

THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients

AB0709 Switching from originator infliximab to biosimilar infliximab: efficacy and safety in a cohort of patients with established behÇet’s disease

The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA

Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies

THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis

OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors

Adalimumab in the Treatment of Immune-Mediated Diseases

SAT0265 Secondary Sjogren's Syndrome in Patients with Spondyloarthritis

Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)

Bosentan fosters microvascular de-remodelling in systemic sclerosis

Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

AB0770 Rheuma-card: involvement of the patient through a secure systems access into the treat to target strategy in rheumatology

Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension

Suchergebnisse filtern